Dr. Theresa LaVallee
There is a new Vice President of translational Medicines at Connecticut, US-based biopharma company Kolltan Pharmaceuticals in the form of Dr. Theresa LaVallee.
LaVallee most recently served as Senior Director, Translational Medicine at MedImmune, the global biologics arm of AstraZeneca and has over 25 years of experience in the industry.
Dr. Jerry McMahon, President and CEO of the company said of LaVallee: “Her leadership experience and record of success in the biotechnology industry and her scientific background in oncology and inflammation make her a great addition as head of our translational medicine effort as we advance our products toward the clinic.”